• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Kohl Simeon covered exercise/tax liability with 35,819 shares and converted options into 91,725 shares, increasing direct ownership by 10% to 619,309 units (SEC Form 4)

    8/20/25 12:29:07 PM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary
    Get the next $PHLT alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Kohl Simeon

    (Last) (First) (Middle)
    900 SOUTH PINE ISLAND ROAD
    SUITE 150

    (Street)
    PLANTATION FL 33324

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Performant Healthcare Inc [ PHLT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    08/18/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, par value $0.0001 per share 08/19/2025 M 91,725 A $0 655,128 D
    Common Stock, par value $0.0001 per share 08/19/2025 F 35,819(1) D $7.61 619,309 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units $0(2) 08/18/2025 M 91,725 (3)(4)(5)(6)(7) (3)(4)(5)(6)(7) Common Stock 91,725 $0(2) 91,724 D
    Explanation of Responses:
    1. Shares surrendered to pay tax liability due on vesting of Restricted Stock Units
    2. Each restricted stock unit represents a contingent right to receive one share of PHLT's common stock. The units were awarded at no cost to the Reporting Person.
    3. Restricted Stock Unit Award was granted on May 5, 2023 (the "Grant Date"). These Restricted Stock Units shall vest over a four year period based upon continuous service through each vesting date and the trading price of the Company's Common Stock during the relevant vesting period, subject to accelerated vesting pursuant to the terms of the Reporting Person's Change in Control and Severance Agreement. Specifically, and subject to the vesting limitations described below, the average trading price for Company's shares for 60 consecutive trading days will be measured against the Target Stock Price Hurdles. Target Stock Price Hurdles are increases by year of +25%, +50%, +75%, and +100% versus initial stock price based on 60-day VWAP of $3.16 per share of one share on the Grant Date in each of the four years following the Grant Date.
    4. The vesting for the Restricted Stock Units and associated Stock Price Hurdles will be allocated into the following four tranches: (i) Tranche 1, 25% Vesting Percentage, $3.95 Stock Price Hurdle; (ii) Tranche 2, 50% Vesting Percentage, $4.74 Stock Price Hurdle; (iii) Tranche 3, 75% Vesting Percentage, $5.52 Stock Price Hurdle; and (iv) Tranche 4, 100% Vesting Percentage, $6.31 Stock Price Hurdle. The Restricted Stock Units within each Tranche will vest in accordance with the following: For Tranche 1, Reporting Person shall have up to three years to achieve the Stock Price Hurdle. If the Stock Price Hurdle is achieved before 12 months, Reporting Person vests in the Tranche 1 RSUs at 12 months. If the Stock Price Hurdle is achieved in month 13 - 36, Reporting Person vests in the Tranche 1 RSUs whenever the Stock Price Hurdle is achieved. If the Stock Price Hurdle is not achieved by 36 months, the RSUs tied to Tranche 1 are forfeited.
    5. For Tranche 2, Reporting Person shall have up to three years to achieve the Stock Price Hurdle. If the Stock Price Hurdle is achieved before 24 months, Reporting Person vests in the Tranche 2 RSUS at 24 months. If the Stock Price Hurdle is achieved in month 25 - 36, Reporting Person vests in the Tranche 2 RSUs whenever the Stock Price Hurdle is achieved. If the Stock Price Hurdle is not achieved by 36 months, the RSUs tied to Tranche 2 are forfeited.
    6. For Tranche 3, Reporting Person shall have up to four years to achieve the Stock Price Hurdle. If the Stock Price Hurdle is achieved before 36 months, Reporting Person vests in the Tranche 3 RSUs at 36 months. If the Stock Price Hurdle is achieved in month 37 - 48, Reporting Person vests in the Tranche 3 RSUs whenever the Stock Price Hurdle is achieved. If the Stock Price Hurdle is not achieved by 48 months, the RSUs tied to Tranche 3 are forfeited.
    7. For Tranche 4, Reporting Person shall have up to four years to hit the Stock Price Hurdle. If the Stock Price Hurdle is achieved before 48 months, Reporting Person vests in the Tranche 4 RSUs 48 months. If the Stock Price Hurdle is not achieved by 48 months, the RSUs tied to Tranche 4 are forfeited.
    Remarks:
    /s/ Rohit Ramchandani, Attorney-in-Fact for Simeon M. Kohl 08/20/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $PHLT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PHLT

    DatePrice TargetRatingAnalyst
    7/10/2025$8.00Mkt Outperform
    Citizens JMP
    More analyst ratings

    $PHLT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Yanagi Eric returned 3,261,675 shares to the company and disposed of 381,835 shares, closing all direct ownership in the company (SEC Form 4)

    4 - Performant Healthcare Inc (0001550695) (Issuer)

    10/22/25 1:24:44 PM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    Director Hansen William Dean returned 464,115 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - Performant Healthcare Inc (0001550695) (Issuer)

    10/21/25 12:11:37 PM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    Director Im Lisa returned 1,229,413 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - Performant Healthcare Inc (0001550695) (Issuer)

    10/21/25 12:09:43 PM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    $PHLT
    SEC Filings

    View All

    SEC Form EFFECT filed by Performant Healthcare Inc.

    EFFECT - Performant Healthcare Inc (0001550695) (Filer)

    11/21/25 12:15:05 AM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Performant Healthcare Inc.

    SCHEDULE 13G/A - Performant Healthcare Inc (0001550695) (Subject)

    11/13/25 4:49:31 PM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    SEC Form 15-12G filed by Performant Healthcare Inc.

    15-12G - Performant Healthcare Inc (0001550695) (Filer)

    10/31/25 4:56:51 PM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    $PHLT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Machinify Completes Acquisition of Performant Healthcare, Accelerating Intelligent Healthcare Payments

    The New Mountain Capital backed company closes its second major acquisition in 2025 to expand its AI-powered operating system to a broader range of clients. Machinify, a leading healthcare intelligence company with expertise across the payment continuum, today announced the close of its acquisition of Performant Healthcare, Inc. (NASDAQ:PHLT) for approximately $670 million. The deal expands Machinify's AI-powered platform to reach a broader range of clients, including government programs, and accelerates its mission to simplify and modernize healthcare payments. "We're thrilled to bring Performant into Machinify with such highly complementary assets," said David Pierre, CEO of Machinify

    10/21/25 9:12:00 AM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    Performant Healthcare, Inc. Announces Preliminary Financial Results for Second Quarter 2025

    Performant Healthcare, Inc. (NASDAQ:PHLT) (the "Company" or "Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, today announced preliminary financial results for the second quarter of 2025. Second Quarter 2025 Results The Company currently expects to file its Form 10-Q for the quarter ended June 30, 2025 on August 7, 2025 and anticipates reporting second quarter revenues of approximately $37.8 million, net income of approximately $2.1 million, and adjusted EBITDA of approximately $6.2 million. Transaction with Machinify In a separate press release issued today, Performant announced its entry into a definitive agreemen

    8/1/25 8:35:00 AM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    Performant Healthcare, Inc. to Be Acquired by Machinify

    Performant stockholders to receive $7.75 in cash per share, a 139% premium to Performant's 90-day VWAP Performant Healthcare, Inc. (NASDAQ:PHLT) (the "Company" or "Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital, which has agreed to acquire Performant for approximately $670 million. Under the terms of the merger agreement, Performant stockholders will receive $7.75 in cash for each share of Performant common stock outstanding at the closing of the transactio

    8/1/25 8:30:00 AM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    $PHLT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citizens JMP initiated coverage on Performant Healthcare with a new price target

    Citizens JMP initiated coverage of Performant Healthcare with a rating of Mkt Outperform and set a new price target of $8.00

    7/10/25 8:59:36 AM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    $PHLT
    Financials

    Live finance-specific insights

    View All

    Performant Healthcare, Inc. Announces Preliminary Financial Results for Second Quarter 2025

    Performant Healthcare, Inc. (NASDAQ:PHLT) (the "Company" or "Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, today announced preliminary financial results for the second quarter of 2025. Second Quarter 2025 Results The Company currently expects to file its Form 10-Q for the quarter ended June 30, 2025 on August 7, 2025 and anticipates reporting second quarter revenues of approximately $37.8 million, net income of approximately $2.1 million, and adjusted EBITDA of approximately $6.2 million. Transaction with Machinify In a separate press release issued today, Performant announced its entry into a definitive agreemen

    8/1/25 8:35:00 AM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    Performant Healthcare, Inc. to Report Second Quarter 2025 Earnings on August 5, 2025

    Performant Healthcare, Inc. (NASDAQ:PHLT) (the "Company", "Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that the company will report its second quarter 2025 results after the market closes Tuesday August 5, 2025. The Company will also hold a conference call to discuss results at 5:00 pm (Eastern Time) that day. To join the conference call: Dial in 800-717-1738 or 646-307-1865, or Live webcast through company's website here Replay can be found approximately three hours after the call on the company website under the Events & Presentations section or by dialing 844-512-2921 (domestic), or 412-317

    7/24/25 9:00:00 AM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    Performant Healthcare, Inc. Announces Financial Results for First Quarter 2025

    Performant Healthcare, Inc. (NASDAQ:PHLT), a leading provider of healthcare payment integrity services, today reported the following financial results for its first quarter ended March 31, 2025: First Quarter 2025 Financial Highlights Total revenue of $33.3 million, compared to total revenue of $27.3 million in the prior year period. Healthcare revenue of $33.2 million, compared to $25.8 million in the prior year period, an increase of approximately 29%. Net loss of $0.1 million, or $0.00 per diluted share, compared to net loss of $4.0 million, or $(0.05) per diluted share, in the prior year period. Adjusted EBITDA of $3.3 million, compared to $(1.2) million in the prior year perio

    5/8/25 4:00:00 PM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary

    $PHLT
    Leadership Updates

    Live Leadership Updates

    View All

    Machinify Completes Acquisition of Performant Healthcare, Accelerating Intelligent Healthcare Payments

    The New Mountain Capital backed company closes its second major acquisition in 2025 to expand its AI-powered operating system to a broader range of clients. Machinify, a leading healthcare intelligence company with expertise across the payment continuum, today announced the close of its acquisition of Performant Healthcare, Inc. (NASDAQ:PHLT) for approximately $670 million. The deal expands Machinify's AI-powered platform to reach a broader range of clients, including government programs, and accelerates its mission to simplify and modernize healthcare payments. "We're thrilled to bring Performant into Machinify with such highly complementary assets," said David Pierre, CEO of Machinify

    10/21/25 9:12:00 AM ET
    $PHLT
    Other Consumer Services
    Consumer Discretionary